glp-1 weight loss covered by insurance Medicaid fuels US coverage of Novo, Lilly weight-loss drugs Medicaid Coverage of and Spending

Funding This work was supported by the National Research Foundation of Korea (NRF) (No

Note that paroxetine and fluoxetine should be avoided in women taking tamoxifen due to drug interactions Gabapentin : an anticonvulsant that may reduce vasomotor symptoms, particularly helpful for women with night sweats, though side effects include dizziness and fatigue Clonidine : an antihypertensive agent with modest efficacy for hot flashes, considered only when other options are unsuitable due to its side effect profile Cognitive behavioural therapy (CBT) : NICE-recommended psychological intervention that helps women manage the impact of symptoms Lifestyle modifications form an important foundation: Maintaining a healthy weight through balanced diet and regular physical activity Wearing layered clothing and keeping ambient temperature cool Avoiding known triggers (alcohol, caffeine, spicy foods) Practising stress-reduction techniques Ensuring good sleep hygiene When to contact your GP : Women should seek medical advice if hot flashes significantly impact quality of life, interfere with sleep or daily activities, or if symptoms occur alongside unexplained weight loss, night sweats with fever, or other concerning features

Management options include dose reduction of the GLP-1 receptor agonist, switching to an alternative agent in the class, or temporarily discontinuing therapy to assess whether heart rate normalizes

It is essential that patients who have used these drugs retain any related medical documentation and further evidence to support their claims

Its almost a question of where are they not ? In fact, these receptors are now known to be abundant throughout the body

Oral GLP-1 Drops: Are They Equally Effective